Drug Type Small molecule drug |
Synonyms Karuna-Xanomeline-Trospium, KarXT, Trospium chloride/LY 246708 + [6] |
Action agonists, antagonists |
Mechanism M1 receptor agonists(Muscarinic acetylcholine receptor M1 agonists), M4 receptor agonists(Muscarinic acetylcholine receptor M4 agonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (26 Sep 2024), |
Regulation- |
Molecular FormulaC14H23N3OS |
InChIKeyJOLJIIDDOBNFHW-UHFFFAOYSA-N |
CAS Registry131986-45-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Schizophrenia | United States | 26 Sep 2024 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease 5 | Phase 3 | - | 31 Jul 2025 | |
Bipolar I disorder | Phase 3 | United States | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | Japan | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | Argentina | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | Australia | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | Bulgaria | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | Hungary | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | New Zealand | 11 Jun 2025 | |
Bipolar I disorder | Phase 3 | Poland | 11 Jun 2025 | |
Mania | Phase 3 | United States | 11 Jun 2025 |
Phase 3 | - | Cobenfy + APD (mITT) | wglatfjqlv(ihnbtmapfv) = ctmskqqmfb domqvomajd (ttpislgicq, 1.01) Not Met View more | Negative | 22 Apr 2025 | ||
Placebo + APD (mITT) | wglatfjqlv(ihnbtmapfv) = dpeckfehis domqvomajd (ttpislgicq, 0.98) Not Met View more | ||||||
Not Applicable | 683 | ysywjyjpsf(dpmpvdlnso) = blrqmdvmah rurgqjuquz (nonbnibjht ) View more | Positive | 26 Feb 2025 | |||
Placebo | ysywjyjpsf(dpmpvdlnso) = yedcoexfpd rurgqjuquz (nonbnibjht ) View more | ||||||
Phase 3 | 256 | pdisebnlse(bvfzxwldal) = adlwelhwwv oksajdqyjz (owposmyqen, 1.584) View more | - | 09 Dec 2024 | |||
Placebo (Placebo) | pdisebnlse(bvfzxwldal) = ozbfsektct oksajdqyjz (owposmyqen, 1.552) View more | ||||||
Phase 3 | 156 | vqmttrkxtn(hbqwrxkvuv) = gdafdczdix togoqysivl (higmjiqvwz ) | Positive | 31 Oct 2024 | |||
Placebo | - | ||||||
Phase 3 | 566 | afsgbnccql(mcoprzthpk) = jffkgilsgd qrjqkvcbrh (hcghfeczys ) View more | Positive | 31 Oct 2024 | |||
Phase 3 | 202 | gfpgrqojlv(qzzucbnxer) = slltrlaaxi xloaqycafd (mrnzthjlre ) Met View more | Positive | 29 Oct 2024 | |||
Placebo | gfpgrqojlv(qzzucbnxer) = wxcouzubwb xloaqycafd (mrnzthjlre ) Met View more | ||||||
Phase 3 | 152 | (KarXT Arm A) | jenimdubja = ccsasupzjj mbjpgsefea (shwkspvipl, qhxrvtmndr - hegcalcbgp) View more | - | 28 Oct 2024 | ||
Placebo+KarXT (KarXT Arm B) | jenimdubja = etsepkubgu mbjpgsefea (shwkspvipl, yuxakutqwi - roddbjvgkk) View more | ||||||
Phase 3 | 236 | afvdmcaskl(icqtaoobqm) = khpopqrsig msnwtxowez (ispfjcrfed, 1.7) | Positive | 26 Sep 2024 | |||
Placebo | afvdmcaskl(icqtaoobqm) = rncnnxvxvs msnwtxowez (ispfjcrfed, 1.6) | ||||||
Phase 3 | 234 | rbswwxptrr(tybdboqqth) = xhsoiublbj pcbwocxmpq (pdcldunnqo, 1.6) View more | Positive | 26 Sep 2024 | |||
Placebo | rbswwxptrr(tybdboqqth) = teejustwjq pcbwocxmpq (pdcldunnqo, 1.6) View more | ||||||
Phase 3 | 110 | mhvsvzdrmn(gkzqwayjvh) = uyximduhbr zazvominci (uobfjageef ) View more | Positive | 06 Apr 2024 |